1. Abstract Colovesical fistulas (CVFs) are significant complications arising from diverticulitis and colorectal cancer. These fistulas create abnormal connections between the colon and bladder, leading to symptoms like pneumaturia and fecaluria. Given the variability in symptoms,
1. Abstract 1.1. Background Ovarian cancer is one of the most common malignant tumors in the female reproductive system. CXC-motif chemokine ligand 10 (CXCL10) increases tumor infiltrating lymphocytes (TIL) infiltration and is closely related to ovarian cancer prognosis.
1. Abstract 1.1. Objective To explore the causal relationships between inflammatory factors and hepatic cancer and identify the role of serum metabolites as potential mediators.
1. Abstract 1.1. Background Two classical models have been proposed for the development of colorectal cancer (CRC) from colon epithelial cells.
1. Abstract A 50-year-old male who presents with worsening left upper quadrant pain for several months. The pain constant and tender over the left ribs, and worse when lying down.
1. Abstract Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is an uncommon but potentially life-threatening form of adverse drug reaction (ADR), most frequently reported with antiepileptics and antibiotics.
1. Abstract Gadolinium-ethoxybenzyl-diethylene-triamine-pentaacetic acid (Gd EOB-DTPA) MRI has the advantage of simultaneously screening for hepatocellular carcinoma (HCC) and evaluating liver damage due to Fontan associated liver disease (FALD), and is suitable.
1. Abstract A 35-year-old woman was treated for complete dysphagia resulting from a chemical burn of the esophagus. Between 2012 and 2019, numerous interventional gastroscopies (4–16 per year) were performed to alleviate her sympoms.
1. Abstract 1.1. Background Although long-term antiviral therapy for chronic hepatitis B virus (HBV) can reverse fibrosis even in patients with liver cirrhosis, fibro sis progression can still occur despite viral suppression.
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.
